Muscular cavernous single cell analysis in patients with venoocclusive dysfunction

Area of Science:

• Urology
• Physiology
• Pharmacology

Background:

• Erectile dysfunction (ED) is a common condition affecting many men.
• Veno-occlusive dysfunction (VOD) is a significant cause of ED.
• Current treatments for ED include medications like papaverine, phentolamine, and prostaglandin E1 (PGE1).

Purpose of the Study:

• To investigate the cellular mechanisms underlying non-response to prostaglandin E1 (PGE1) in patients with erectile dysfunction (ED).
• To assess the function of smooth muscle cells from the corpora cavernosa in patients unresponsive to ED treatments.
• To explore the role of calcium ion (Ca2+) currents in PGE1-induced smooth muscle relaxation in ED.

Main Methods:

• Enzymatic isolation of smooth muscle cells from corpora cavernosa biopsies of 15 ED patients.
• Patch-clamp technique in whole-cell configuration to measure ion currents.
• Simultaneous monitoring of intracellular calcium concentration using FURA-II fluorescence dye.
• Cavernosometry to classify patients based on their response to ED treatments.

Main Results:

• Extracellularly applied PGE1 induced smooth muscle relaxation by inhibiting voltage-dependent L-type Ca2+ currents (58 +/- 8%).
• Smooth muscle cells from 14 out of 15 PGE1 non-responders showed no evidence of functional disturbance.
• Comparison with intact cavernous tissue (n=5) indicated preserved cellular function in most non-responders.

Conclusions:

• Prostaglandin E1 (PGE1) exerts its relaxing effect on smooth muscle by inhibiting L-type calcium channels.
• The lack of response to PGE1 in most ED patients is not due to functional impairment of the smooth muscle cells themselves.
• The precise etiology of veno-occlusive dysfunction in these patients remains to be elucidated, suggesting other factors may be involved.